Hypertension management, a significant risk factor for cardiovascular and kidney diseases, is a leading cause of preventable death and disability globally. With more than 100 million people affected in the US alone, the healthcare costs associated with hypertension surpassed $130 billion between 2003 and 2014. Despite the availability of affordable medications and lifestyle interventions, blood pressure control rates continue to decline.
Recent research suggests an innovative solution: pharmacist-led interventions. Pharmacists, who often see patients more frequently than physicians, are well-positioned to screen and manage hypertension. Numerous clinical trials have demonstrated improved hypertension outcomes through pharmacist-led case-finding and prescribing interventions.
A cost-effectiveness analysis of implementing pharmacist prescribing for hypertension management in the US has yielded promising results. The pharmacist intervention was associated with 2100 fewer cases of cardiovascular disease and 8 fewer cases of kidney disease per 10,000 patients. Furthermore, it resulted in overall cost savings of $10,162 per person.
🌍 How can Egypt’s hepatitis C elimination program inspire other African nations?
Discover how Egypt has set a powerful benchmark for public health excellence through its “100 million Healthier Lives” campaign, achieving Gold-tier certification from the WHO. This article looks into the training initiatives and regional collaboration that are paving the way for health improvements across the continent.
#SyenzaNews #GlobalHealth #HealthcareInnovation #Innovation #HealthForAll
🌍 How do robust regulatory systems impact public health globally?
Senegal and Rwanda have made significant strides by achieving WHO Maturity Level 3 in medicines regulation, enhancing their capability to ensure safe and effective medical products. This accomplishment not only fortifies local health standards but also sets a benchmark for other nations to follow, promoting regional collaboration and economic benefits. Discover how this achievement will impact global health outcomes!
#SyenzaNews #globalhealth #regulatoryaffairs #MarketAccess #innovation
🌍 How close are we to achieving the **95-95-95 HIV targets**?
Explore the latest insights from UNAIDS on the progress and strategic importance of these targets in ending the HIV/AIDS pandemic by 2030. The framework not only focuses on comprehensive testing and treatment but also emphasizes equity in healthcare access across all demographics.
Read more about how we can collectively strive for a future free from HIV/AIDS-related stigma and health inequities.
#SyenzaNews #GlobalHealth #HealthcareInnovation #Healthforall #FutureofHealthcare
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
